Log In
Print
BCIQ
Print
Print this Print this
 

Retavase, Reteplase (rPA)

  Manage Alerts
Collapse Summary General Information
Company Cornerstone Therapeutics Inc.
DescriptionRecombinant plasminogen activator modified to retain activity longer, permitting administration in two single injections
Molecular Target Plasminogen
Mechanism of ActionAnti-thrombotic/thrombolytic
Latest Stage of DevelopmentApproved
IndicationMyocardial infarction (MI)
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today